Page last updated: 2024-08-23

cefaclor anhydrous and Lung Diseases, Obstructive

cefaclor anhydrous has been researched along with Lung Diseases, Obstructive in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dubois, J; Fong, IW; Grossman, R; Laforge, J; Small, D; Zakhari, R1
Butler, T; Phillips, H; Todd, WM; Van Hook, CJ1
Akman, M; Arseven, O; Aydin Tosun, G; Erelel, M; Erk, M; Göylüsün, V; Gür, A; Ilvan, A; Koşar, F; Müsellim, B; Oztürk, S; Soysal, F; Türker, H; Tutluoglu, B; Umut, S; Unutmaz, S; Vahapoglu, H; Yildirim, N; Yilmaz Kuyucu, T; Yilmaz, N1
Braschi, R; Moreo, G; Nani, M; Remotti, G; Sardi, C1

Trials

4 trial(s) available for cefaclor anhydrous and Lung Diseases, Obstructive

ArticleYear
Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1995, Volume: 18, Issue:2

    Topics: Bronchitis; Cefaclor; Clarithromycin; Female; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Streptococcus pneumoniae

1995
A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults.
    Chest, 1993, Volume: 104, Issue:5

    Topics: Acute Disease; Adult; Aged; Bacteria; Cefaclor; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Drug Tolerance; Female; Humans; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Prodrugs; United States

1993
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group.
    Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:3

    Topics: Ampicillin; Anti-Infective Agents; Azithromycin; Cefaclor; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Sulbactam; Treatment Outcome

1999
[Comparison of an antibiotic combination (amoxicillin + clavulanic acid) and cefaclor in the treatment of acute or flare-ups of chronic bronchopneumopathies].
    La Clinica terapeutica, 1988, Sep-30, Volume: 126, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Asthma; Bronchitis; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged

1988